
Monday, December 12, 2022 6:40:28 PM
Too many day traders. We have great products/ pipeline, amazing partnerships and $140 million in cash. We have $2.45/ share in cash.
Amgen bought Horizon today. Big biotechs are buying small biotechs with good pipelines. We are undervalued. Hang in there. Tax loss selling will end soon and we will be over 1.00 in January and up to 2-3 in 6-9 months.


Liked By
Spread the love. Be the first to like this post!
Recent TNXP News
- Tonix Pharmaceuticals Announces Oral Presentations at the World Vaccine Congress • GlobeNewswire Inc. • 03/27/2023 11:00:00 AM
- Tonix Pharmaceuticals Presents Non-Clinical Data on TNX-2900 for the Potential Treatment of Hyperphagia in Adolescents and Young Adults with Prader-Willi Syndrome at the Rare Disease Innovation and Partnership Summit • GlobeNewswire Inc. • 03/23/2023 08:15:00 PM
- Tonix Pharmaceuticals Announces Oral Presentation and Poster at the 5th International Congress on Controversies in Fibromyalgia • GlobeNewswire Inc. • 03/23/2023 11:00:00 AM
- Tonix Pharmaceuticals to Present at the 2023 Virtual March Investor Summit • GlobeNewswire Inc. • 03/22/2023 11:00:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/20/2023 09:09:22 PM
- Tonix Pharmaceuticals Announces Presentation at the Rare Disease Innovation and Partnership Summit • GlobeNewswire Inc. • 03/16/2023 08:05:00 PM
- Tonix Pharmaceuticals Initiates Enrollment in Phase 2 ‘UPLIFT’ Study of TNX-601 ER (Tianeptine Hemioxalate Extended-Release Tablets) for the Treatment of Major Depressive Disorder (MDD) • GlobeNewswire Inc. • 03/16/2023 11:00:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/13/2023 09:29:55 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/13/2023 11:07:01 AM
- Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights • GlobeNewswire Inc. • 03/13/2023 11:00:00 AM
- Tonix Pharmaceuticals Announces Results from a Preclinical Study of Murine TNX-1700 Presented in a Poster at the Keystone Symposia, “Cancer Immunotherapy: Mechanisms of Response Versus Resistance” • GlobeNewswire Inc. • 03/07/2023 12:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/27/2023 12:03:12 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/24/2023 11:39:28 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/24/2023 11:39:08 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/24/2023 11:38:13 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/24/2023 11:35:15 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/23/2023 09:23:39 PM
- Tonix Pharmaceuticals Announces New Board Member, R. Newcomb Stillwell • GlobeNewswire Inc. • 02/23/2023 09:15:00 PM
- Tonix Pharmaceuticals Describes Emerging Research on the Incidence of Multi-Site Pain Symptoms in Long COVID Patients During Event Titled, “Long COVID: What Will it Take to Accelerate Therapeutic Progress?” • GlobeNewswire Inc. • 02/22/2023 12:00:00 PM
- Tonix Pharmaceuticals to Participate in Event Titled, “Long COVID: What Will it Take to Accelerate Therapeutic Progress?” • GlobeNewswire Inc. • 02/16/2023 12:00:00 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 09:02:00 PM
- New to The Street Announces its Line-up, Four Interviews on Episode #438, Airing on the Fox Business Network, Tonight, Monday, February 13, 2023, 10:30 PM PT • GlobeNewswire Inc. • 02/13/2023 02:30:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/13/2023 12:06:31 PM
- Tonix Pharmaceuticals Announces Exclusive License of Potential Therapeutic or Preventative Fully Human and Murine Anti-SARS-CoV-2 Monoclonal Antibodies • GlobeNewswire Inc. • 02/13/2023 12:00:00 PM
- New to The Street / Newsmax TV Announces its Four Corporate Interviews on Episode #437, Broadcast, Saturday, February 11, 2023, 3:30 PM ET • GlobeNewswire Inc. • 02/10/2023 02:30:00 PM
Metatron Releases All-in-One Artificial Intelligence Mobile Apps for iPhone and Android • MRNJ • Mar 27, 2023 9:00 AM
Memorandum of Understanding With Miranda Water Treatment Systems and Rainmaker Worldwide Inc. Extended • RAKR • Mar 27, 2023 8:50 AM
Hollywall Entertainment Inc., (OTC:HWAL) Announces the completion of its 2021 and 2020 Audit (s) • HWAL • Mar 24, 2023 12:48 PM
Glucose Health, Inc. Fiscal 2022 Annual Report • GLUC • Mar 23, 2023 3:23 PM
Nextech3D.ai Announces Its AI-Powered SaaS Platform Toggle3D Experiences A +963% Jump in Users in 60-Days Crossing Over 1000 Users • NTAR • Mar 23, 2023 7:07 AM
Lifecycle Assessment by Benchmark Shows TMC's NORI-D Nodule Project Could Outperform Land-Based Routes of Producing Nickel, Copper and Cobalt in Almost Every Impact Category Analyzed • TMC • Mar 22, 2023 1:44 PM